These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 31793421)

  • 21. Targeted drug delivery to the brain using magnetic nanoparticles.
    Thomsen LB; Thomsen MS; Moos T
    Ther Deliv; 2015; 6(10):1145-55. PubMed ID: 26446407
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chapter 1 - Drug delivery to the brain using colloidal carriers.
    Chang J; Jallouli Y; Barras A; Dupont N; Betbeder D
    Prog Brain Res; 2009; 180():2-17. PubMed ID: 20302826
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Learning from our failures in blood-brain permeability: what can be done for new drug discovery?
    Martel S
    Expert Opin Drug Discov; 2015 Mar; 10(3):207-11. PubMed ID: 25658294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Noninvasive nanoparticle strategies for brain tumor targeting.
    Sun C; Ding Y; Zhou L; Shi D; Sun L; Webster TJ; Shen Y
    Nanomedicine; 2017 Nov; 13(8):2605-2621. PubMed ID: 28756093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Strategies for drug delivery to the central nervous system by systemic route.
    Kasinathan N; Jagani HV; Alex AT; Volety SM; Rao JV
    Drug Deliv; 2015 May; 22(3):243-57. PubMed ID: 24471801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug delivery to the brain--realization by novel drug carriers.
    Müller RH; Keck CM
    J Nanosci Nanotechnol; 2004 May; 4(5):471-83. PubMed ID: 15503432
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent advances in drug delivery and targeting to the brain.
    Sethi B; Kumar V; Mahato K; Coulter DW; Mahato RI
    J Control Release; 2022 Oct; 350():668-687. PubMed ID: 36057395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nanosized Drug Delivery Systems for Direct Nose to Brain Targeting: A Review.
    Phukan K; Nandy M; Sharma RB; Sharma HK
    Recent Pat Drug Deliv Formul; 2016; 10(2):156-64. PubMed ID: 26996366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Micro- and nanoparticles--medical applications.
    Jătariu A; Peptu C; Popa M; Indrei A
    Rev Med Chir Soc Med Nat Iasi; 2009; 113(4):1160-9. PubMed ID: 20191893
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nanotechnology in therapeutics: a focus on nanoparticles as a drug delivery system.
    Bamrungsap S; Zhao Z; Chen T; Wang L; Li C; Fu T; Tan W
    Nanomedicine (Lond); 2012 Aug; 7(8):1253-71. PubMed ID: 22931450
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nanomedicine as a non-invasive strategy for drug delivery across the blood brain barrier.
    Tam VH; Sosa C; Liu R; Yao N; Priestley RD
    Int J Pharm; 2016 Dec; 515(1-2):331-342. PubMed ID: 27769885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emerging blood-brain-barrier-crossing nanotechnology for brain cancer theranostics.
    Tang W; Fan W; Lau J; Deng L; Shen Z; Chen X
    Chem Soc Rev; 2019 Jun; 48(11):2967-3014. PubMed ID: 31089607
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advances in nanomedicine for the treatment of Alzheimer's and Parkinson's diseases.
    Hernando S; Gartziandia O; Herran E; Pedraz JL; Igartua M; Hernandez RM
    Nanomedicine (Lond); 2016 May; 11(10):1267-85. PubMed ID: 27077453
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Delivery of drugs to the brain via the blood brain barrier using colloidal carriers.
    Tucker IG; Yang L; Mujoo H
    J Microencapsul; 2012; 29(5):475-86. PubMed ID: 22563886
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advances in brain drug targeting and delivery: limitations and challenges of solid lipid nanoparticles.
    Patel M; Souto EB; Singh KK
    Expert Opin Drug Deliv; 2013 Jul; 10(7):889-905. PubMed ID: 23550609
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exosome-Based Macromolecular neurotherapeutic drug delivery approaches in overcoming the Blood-Brain barrier for treating brain disorders.
    Yadav K; Vijayalakshmi R; Kumar Sahu K; Sure P; Chahal K; Yadav R; Sucheta ; Dubey A; Jha M; Pradhan M
    Eur J Pharm Biopharm; 2024 Jun; 199():114298. PubMed ID: 38642716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Micro- and nanotechnology approaches to improve Parkinson's disease therapy.
    Torres-Ortega PV; Saludas L; Hanafy AS; Garbayo E; Blanco-Prieto MJ
    J Control Release; 2019 Feb; 295():201-213. PubMed ID: 30579984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug targeting to brain: a systematic approach to study the factors, parameters and approaches for prediction of permeability of drugs across BBB.
    Nagpal K; Singh SK; Mishra DN
    Expert Opin Drug Deliv; 2013 Jul; 10(7):927-55. PubMed ID: 23330786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Receptor Targeted Polymeric Nanostructures Capable of Navigating across the Blood-Brain Barrier for Effective Delivery of Neural Therapeutics.
    Dube T; Chibh S; Mishra J; Panda JJ
    ACS Chem Neurosci; 2017 Oct; 8(10):2105-2117. PubMed ID: 28768412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Progress in the Application of Nanoparticles and Graphene as Drug Carriers and on the Diagnosis of Brain Infections.
    Barani M; Mukhtar M; Rahdar A; Sargazi G; Thysiadou A; Kyzas GZ
    Molecules; 2021 Jan; 26(1):. PubMed ID: 33401658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.